SARCOSYL-PAGE: A new method for the detection of MIRCERA-and EPO-doping in blood

Drug Testing and Analysis

Volumn 1, Issue 11-12, 2009, Pages 494-504

  Reichel, Christian ^a   Abzieher, Friedrich ^a   Geisendorfer, Thomas ^a  

^a AIT Seibersdorf Laboratories   (Austria)

Author keywords

Doping control; Erythropoietin; MIRCERA; SARCOSYL PAGE; SDS PAGE

Indexed keywords

AMINO ACIDS; BLOOD; CHAINS; ELECTROPHORESIS; PROTEINS; SODIUM DODECYL SULFATE; SULFUR COMPOUNDS;

BRAND NAMES; DOPING CONTROL; ERYTHROPOIESIS-STIMULATING AGENTS; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTORS; MIRCERA; RECEPTOR ACTIVATOR; SARCOSYL; SARCOSYL-PAGE; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS;

MOLECULES;

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD; BLOOD ANALYSIS; DOPING; DRUG DETERMINATION; DRUG EXCRETION; DRUG SCREENING; HUMAN; HUMAN EXPERIMENT; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 77950567285     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.97     Document Type: Article

References (49)

1. F. Lasne, L. Martin, J. A. Martin, J. de Ceaurriz, Haematologica 2009, 94, 888.
2. M. Kohler, C. Ayotte, P. Desharnais, U. Flenker, S. Lüdke, M. Thevis, E. Völker-Schänzer, W. Schänzer, Int. J. Sports Med. 2008, 29, 1.
3. C. Reichel, R. Kulovics, V. Jordan, M. Watzinger, T. Geisendorfer, Drug Test. Analysis 2009, 1, 43.
4. W. Jelkmann, Curr. Med. Chem. 2009, 16, 1236.
5. F. Lasne, J. de Ceaurriz, Nature 2000, 405, 635.
6. P. Desharnais, C. Ayotte, in Recent Advances in Doping Analysis (15), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck), Sportverlag Strauß: Köln, 2007, p. 303.
7. World Anti-Doping Agency, 2009, 1-9, www.wada-ama.org/rtecontent/ document/td2009eop-en.pdf, accessed 27 November 2009.
8. M. Jarsch, M. Brandt, M. Lanzendörfer, A. Haselbeck, Pharmacology 2008, 81, 63.
9. S. G. Elliott, in Erythropoietins and Erythropoiesis, (Eds: G. Molineux, M. A. Foote, S. G. Elliott), Birkhäuser Verlag: Basel, 2006, pp. 246.
10. Y. W. Cho, J. H. Park, J. S. Park, K. Park, in Handbook of Pharmaceutical Biotechnology, (Ed: S. C.Gad), Wiley: Hoboken, 2007, pp. 443.
11. I. C. Macdougall, R. Robson, S. Opatrna, X. Liogier, A. Pannier, P. Jordan, F. C. Dougherty, B. Reigner, Clin. J. Am. Soc. Nephrol. 2006, 1, 1211.
12. G. Pasut, F. M. Veronese, Adv. Polym. Sci. 2006, 192, 95.
13. D. E. Mager, M. Ramanathan, in Handbook of Pharmaceutical Biotechnology, (Ed: S. C. Gad), John Wiley & Sons, Inc.: Hoboken, 2007, pp. 259.
14. S. V. Balu-Iyer, R. D. Miclea, V. S. Purohit, in Handbook of Pharmaceutical Biotechnology, (Ed: S. C. Gad), John Wiley & Sons, Inc.: Hoboken, 2007, pp. 749.
15. W. Jelkmann, Br. J. Haematol. 2008, 141, 287.
16. I. C. Macdougall, M. Ashenden, Advances in Chronic Kidney Disease 2009, 16, 117.
17. S. S. Park, J. Park, J. Ko, L. Chen, D. Meriage, L. Crouse-Zeineddini, W. Wong, B. A. Kerwin, J. Pharm. Sci. 2009, 98, 1688.
18. H. Schellekens, EHLP Journal 2004, 3, 43.
19. F. Lasne, in Pharmacology, Doping and Sports, (Ed: J. L.Fourcroy), Routledge: New York, 2009, pp. 107.
20. S. Lamon, S. Giraud, L. Egli, J. Smolander, M. Jarsch, K. G. Stubenrauch, A. Hellwig, M. Saugy, N. Robinson, J. Pharm. Biomed. Anal. 2009, 50, 954.
21. MicroCoat Biotechnology GmbH, 2009, MIRCERA ELISA Instruction Manual, version 1, June 2009, pp. 1.
22. V. Skibeli, G. Nissen-Lie, P. Torjesen, Blood 2001, 98, 3626.
23. F. Lasne, L. Martin, J. A. Martin, J. de Ceaurriz, Int. J. Biol. Macromol. 2007, 41, 354.
24. Invitrogen, in NuPAGE Technical Guide Version E (IM-1001), Carlsbad, 2003, p 49.
25. C. Y. Zheng, G. Ma, Z. Su, Electrophoresis 2007, 28, 2801.
26. O. J. Bjerrum, C. Schafer-Nielsen, in Electrophoresis '86, (Ed: M. J. Dunn), Wiley-VCH: Weinheim, 1986, pp. 315.
27. F. Lasne, L. Martin; N. Crepin, J. de Ceaurriz, Anal. Biochem. 2002, 311, 119.
28. F. Lasne, J. Immunol. Methods 2003, 276, 223.
29. I. Bajla, I. Holländer, M. Minichmayr, G. Gmeiner, C. Reichel, Comput. Methods Programs Biomed. 2005, 80, 246.
30. European Medicines Agency (EMEA), 2007, 1-4, www.emea.europa.eu/ humandocs/PDFs/EPAR/mircera/H-739-en6.pdf, accessed 27 November 2009.
31. M. M. Kurfürst, Anal. Biochem. 1992, 200, 244.
32. O. W. Odom, W. Kudlicki, G. Kramer, B. Hardesty, Anal. Biochem. 1997, 245, 249.
33. R. E. Akins, R. S. Tuan, in The Protein Protocols Handbook (2nd edition), (Ed: J. M. Walker), Humana Press: Totowa, 2002, pp. 81.
34. X. Lu, Y. Yao, W. Zhang, Electrophoresis 2007, 28, 3174.
35. D. Ochs, C. H. Tappe, P. Gärtner, R. Keller, K. Poralla, Eur. J. Biochem. 1990, 194, 75.
36. E. L. Kannenberg, E. A. Rathbun, N. J. Brewin, Mol. Microbiol. 1992, 6, 2477.
37. M. M. Lucas, J. L. Peart, N. J. Brewin, E. L. Kannenberg, J. Bacteriol. 1996, 178, 2727.
38. H. Schägger, G. von Jagow, Anal. Biochem. 1991, 199, 223.
39. P.G. Righetti, A. V. Stoyanov, M.Y. Zhukov, inThe Proteome Revisited, Elsevier: Amsterdam, 2001, p. 239.
40. I. A. Nnanna, G. Y. Cheng, J. Xia, in Protein-based Surfactants. Marcel Dekker: New York, 2001, pp. 235.
41. J. Roskams, L. Rogers, in Lab Ref: A Handbook of Recipes, Reagents, and other Reference Tools for Use at the Bench, CSHL Press: Cold Spring Harbor, 2002, p. 49.
42. W. H. Evans, J. W. Gurd, Biochem. J. 1973, 133, 189.
43. S. Frankel, R. Sohn, L. Leinwand, Proc. Natl. Acad. Sci. USA 1991, 88, 1192.
44. J. Hibbs, in Chemistry and Technology of Surfactants, (Ed: R. J. Farn), Blackwell Publishing: Oxford, 2006, pp. 127.
45. A. W. Wognum, P. M. Lansdorp, A. C. Eaves, G. Krystal, Blood 1989, 74, 622.
46. A. W. Wognum, P. M. Lansdorp, G. Krystal, Exp. Hematol. 1990, 18, 228.
47. U. K. Laemmli, Nature 1970, 227, 680.
48. D.M. Neville, J. Biol. Chem. 1971, 246, 6328.
49. R. C. Allen, D. J. Moore, Electrophoretic System, U.S. Patent 3620947, 1971.